Long-term efficacy of Rituximab in anti-mag polyneuropathy

被引：0
|
作者：
Benedetti, L.
Briani, C.
Carpo, M.
Cocito, D.
Vigo, T.
Beronio, A.
Zara, G.
Zambello, R.
Sormani, M. P.
Mancardi, G. L.
Nobile-Orazio, E.
Schenone, A.
机构：
[1] Univ Genoa, Genoa, Italy
[2] Univ Padua, I-35100 Padua, Italy
[3] Univ Milan, I-20122 Milan, Italy
[4] Univ Turin, I-10124 Turin, Italy
[5] Human Clin Inst, Milan, Italy
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2007年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [21] B-cell-activating factor in rituximab-treated patients with anti-MAG polyneuropathy
    Benedetti, Luana
    Zardini, Elisabetta
    Briani, Chiara
    Beronio, Alessandro
    Gastaldi, Stefania
    Jarius, Sven
    Mancardi, Gian Luigi
    Schenone, Angelo
    Franciotta, Diego
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (11): : 1291 - 1294
  • [22] Rituximab in anti-MAG neuropathy: More evidence for efficacy and more predictive factors
    Dalakas, Marinos C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 377 : 224 - 226
  • [23] Coexistence of anti-MAG demyelinating polyneuropathy and CREST syndrome
    Zouvelou, V.
    Andreadou, E.
    Kolovou, D.
    Davaki, P.
    Sfagos, C.
    Kilindireas, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 145 - 145
  • [24] Anti-MAG associated cerebellar ataxia and response to rituximab
    Zis, Panagiotis
    Rao, Dasappaiah Ganesh
    Hoggard, Nigel
    Sarrigiannis, Ptolemaios Georgios
    Hadjivassiliou, Marios
    JOURNAL OF NEUROLOGY, 2018, 265 (01) : 115 - 118
  • [25] Anti-MAG associated cerebellar ataxia and response to rituximab
    Panagiotis Zis
    Dasappaiah Ganesh Rao
    Nigel Hoggard
    Ptolemaios Georgios Sarrigiannis
    Marios Hadjivassiliou
    Journal of Neurology, 2018, 265 : 115 - 118
  • [26] Worsening after rituximab treatment in anti-MAG neuropathy
    Broglio, L
    Lauria, G
    MUSCLE & NERVE, 2005, 32 (03) : 378 - 379
  • [27] Worsening after rituximab treatment in anti-MAG neuropathy
    Broglio, L
    Lauria, G
    JOURNAL OF NEUROLOGY, 2005, 252 : 156 - 157
  • [28] Rituximab in Polyneuropathies with Anti-MAG Antibodies: Efficacy, Tolerance and Predictive Factors of Response to Treatment
    Desnuelle, Claude
    Jeandel, Pierre-Yves
    Benaim, Charles
    Fuzibet, Jean Gabriel
    Delmont, Emilien
    NEUROLOGY, 2010, 74 (09) : A526 - A526
  • [29] Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies
    Vallat, Jean-Michel
    Magy, Laurent
    Ciron, Jonathan
    Corcia, Philippe
    Le Masson, Gwendal
    Mathis, Stephane
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (09) : 1111 - 1119
  • [30] RETREATMENT WITH RITUXIMAB IN ANTI-MAG POLYNEUROPATHY: IS THE B-CELL-ACTIVATING FACTOR (BAFF) A NEGATIVE PROGNOSTIC FACTOR?
    Garnero, M.
    Franciotta, D.
    Briani, C.
    Campagnolo, M.
    Grandis, M.
    Fabbri, S.
    Beronio, A.
    Mancardi, G. L.
    Schenone, A.
    Benedetti, L.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 : S19 - S19
12345